insights_auto
Why is TCRX down 4,40%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
0,16 $
arrow_downward
-4,40%(-0,0074) 1D
13 қар., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
0,17 $
High
0,17 $
Low
0,16 $
Mkt. cap
10,76 млн
Avg. vol.
547,00 м.
Volume
227,68 м.
52-wk high
1,47 $
52-wk low
0,16 $
EPS
-0,91 $
Beta
1,21
Shares outstanding
63,50 млн
No. of employees
43
Open
0,17 $
High
0,17 $
Low
0,16 $
Mkt. cap
10,76 млн
Avg. vol.
547,00 м.
Volume
227,68 м.
52-wk high
1,47 $
52-wk low
0,16 $
EPS
-0,91 $
Beta
1,21
Shares outstanding
63,50 млн
No. of employees
43
News stories
From web sources and news partners
BigGo Finance
·
10 сағат бұрын
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
Benzinga
·
3 сағат бұрын
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
The Motley Fool
·
5 сағат бұрын
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
7 сағат бұрын
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
About Tscan Therapeutics Inc
CEO-
Employees43
Founded2018
HeadquartersWaltham, Массачусетс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitetscan.com